The Biden-Harris administration’s latest attack on American innovation is aimed at artificial intelligence.

Intellectual property rights should be protected when artificial intelligence is used in creative works.

USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.

There is nothing more important to strengthening innovation than protecting and promoting intellectual property in healthcare.

Pharmaceutical price controls in President Biden's budget and the SMART Choices Act will devastate drug development.

Intellectual property rights must be protected to encourage future research and development of life saving cures. 

April 26, 2023 celebrates Women in IP, which should provide focus on protecting their intellectual property rights.

The Inflation Reduction Act of 2022 will raise taxes, increase spending, and prolong both inflation and the recession.

Senators should reject price controls on pharmaceuticals; they will not lower prices and lead to fewer future cures.

Sen. Elizabeth Warren (D-Mass.) urges HHS to steal and redistribute intellectual property as a mechanism to lower drug prices.